Spero Therapeutics Inc (SPRO) has fallen 2.23% Monday In Premarket Trading

Spero Therapeutics Inc (SPRO) is lower by Monday morning, with the stock decreasing -2.23% in pre-market trading to 1.75. SPRO's short-term technical score of 74 indicates that the stock has traded more bullishly over the last month than 74% of stocks on the market. In the Biotechnology industry, which ranks 99 out of 146 industries, SPRO ranks higher than 86% of stocks. Spero Therapeutics Inc has risen 16.99% over the past month, closing at $1.53 on February 19. During this period of time, the stock fell as low as $1.47 and as high as $1.89. SPRO has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.

SPRO has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on SPRO!

See Full SPRO Report

Spero Therapeutics Inc has a Long-Term Technical rank of 84. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 16% of the market scoring higher. In the Biotechnology industry which is number 71 by this metric, SPRO ranks better than 71% of stocks.

Important Dates for Investors in SPRO:

-Spero Therapeutics Inc is set to release earnings on 2024-05-09. Over the last 12 months, the company has reported EPS of $0.39. -We do not have a set dividend date for Spero Therapeutics Inc at this time. Click Here To Get The Full Report on Spero Therapeutics Inc (SPRO)